Showing results (411-420 of 446) with videos related to

Sort By:
Pageof 45
Advanced Healthcare Materials|October 26, 2024
A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine AdjuvantErin M Euliano, Brett H Pogostin, Anushka Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinomaHoward A Burris, Lee S Rosen, Caio M Rocha-Lima, et al.
The Journal of Biological Chemistry|February 1, 2002
DNA polymerase lambda, a novel DNA repair enzyme in human cellsMiguel García-Díaz, Katarzyna Bebenek, Rosario Sabariegos, et al.
British Journal of Haematology|August 1, 2012
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomibRavi Vij, David S Siegel, Sundar Jagannath, et al.
Plos One|October 7, 2009
Characterization of a natural mutator variant of human DNA polymerase lambda which promotes chromosomal instability by compromising NHEJGloria Terrados, Jean-Pascal Capp, Yvan Canitrot, et al.
Molecular Cell|July 7, 2010
A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repairAgata Smogorzewska, Rohini Desetty, Takamune T Saito, et al.
Seminars in Arthritis and Rheumatism|August 22, 2025
Risk and temporal trends of heart failure subtypes in rheumatoid arthritisTate M Johnson, Yangyuna Yang, Punyasha Roul, et al.
Nucleic Acids Research|April 16, 2025
Molecular basis for RNA discrimination by human DNA ligase 1Percy P Tumbale, Thomas J Jurkiw, Juno M Krahn, et al.
The EMBO Journal|April 30, 2015
Okazaki fragment maturation involves α-segment error editing by the mammalian FEN1/MutSα functional complexSongbai Liu, Guojun Lu, Shafat Ali, et al.
ACR Open Rheumatology|July 26, 2023
Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic TherapyBeth I Wallace, Bryant R England, Joshua F Baker, et al.
Pageof 45